Description
PT-141 (bremelanotide) is a synthetic cyclic compound and melanocortin receptor agonist studied in preclinical and clinical research settings. Unlike compounds that act on vascular pathways, PT-141 is of research interest for its activity at melanocortin receptors in the central nervous system, and it has been studied in models exploring pathways related to sexual motivation and arousal —distinguishing its proposed mechanism from PDE5 inhibitors, which act peripherally on blood flow.
- Increases Sexual Desire: It targets the central nervous system and hypothalamus to stimulate sexual motivation and libido, rather than just affecting blood flow.
- FDA Approval for Women: It is FDA-approved under the brand name Vyleesi to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women.
- Alternative for Men: It is used off-label in men to help improve low libido and address sexual dysfunction, especially when traditional blood-flow medications like Viagra are insufficient.
PT-141, supplied as 10mg lyophilized powder, ≥99% purity, verified by third-party analytical testing. For laboratory research use only — not for human consumption, diagnostic, or therapeutic use. Certificate of Analysis available on request. Store at -20°C prior to use.
CAS Number: 1607799-13-2
SEQUENCE: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH
Amino Acid Chain Length: 7
Molecular Formula: C50H68N14O10
• For Research use only
• Not for human use
• 99% Pure
• Independent Lab Tested

Reviews
There are no reviews yet.